SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

SAN

86.18

+0.87%↑

MRK1

111.9

+1.63%↑

ARGX

801

-0.25%↓

PHIA

23.43

+0.26%↑

ONC.US

347.12

-0.66%↓

Home・Akciju saraksts・Vetoquinol SA

Vetoquinol SA

Slēgts

SektorsVeselības aprūpe

71.8 1.84

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

Max

71.8

Galvenie mērījumi
By Trading Economics
Ienākumi	-9.8M 25M
Pārdošana	-17M 258M
P/E Sektora vidējais	13.902 106.172
Dividenžu ienesīgums	1.23
Peļņas marža	9.734
Darbinieki	2,497
EBITDA	-12M 48M

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	1.23% 2.31%

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-71M 839M
Iepriekšējā atvēršanas cena	69.96
Iepriekšējā slēgšanas cena	71.8

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

72.6 / 75.1 Atbalsts un pretestība

Vetoquinol SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. nov. 10:30 UTC

Peļņas

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

2025. g. 22. nov. 10:30 UTC

Iegādes, apvienošanās, pārņemšana

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

2025. g. 22. nov. 09:20 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 21. nov. 22:42 UTC

Tirgus saruna

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

2025. g. 21. nov. 21:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 21. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 21. nov. 21:47 UTC

Tirgus saruna

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

2025. g. 21. nov. 21:43 UTC

Tirgus saruna

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

2025. g. 21. nov. 20:18 UTC

Tirgus saruna

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

2025. g. 21. nov. 20:14 UTC

Tirgus saruna

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

2025. g. 21. nov. 19:48 UTC

Tirgus saruna

Precious Metals Fall for the Week -- Market Talk

2025. g. 21. nov. 19:44 UTC

Peļņas

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

2025. g. 21. nov. 19:37 UTC

Tirgus saruna

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

2025. g. 21. nov. 19:27 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2025. g. 21. nov. 19:27 UTC

Tirgus saruna

Peļņas

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

2025. g. 21. nov. 19:20 UTC

Tirgus saruna

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

2025. g. 21. nov. 18:44 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

2025. g. 21. nov. 18:37 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

2025. g. 21. nov. 18:34 UTC

Tirgus saruna

Peļņas

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

2025. g. 21. nov. 18:28 UTC

Peļņas

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

2025. g. 21. nov. 18:03 UTC

Tirgus saruna

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

2025. g. 21. nov. 17:24 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 21. nov. 17:24 UTC

Tirgus saruna

Intuit Seen on Path to Increase Growth -- Market Talk

2025. g. 21. nov. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 21. nov. 17:05 UTC

Tirgus saruna

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

2025. g. 21. nov. 16:56 UTC

Tirgus saruna

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

2025. g. 21. nov. 16:47 UTC

Tirgus saruna

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

2025. g. 21. nov. 16:35 UTC

Iegādes, apvienošanās, pārņemšana

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

2025. g. 21. nov. 16:09 UTC

Peļņas

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

2025. g. 21. nov. 15:59 UTC

Tirgus saruna

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

Salīdzinājums

Cenas izmaiņa

Vetoquinol SA Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Vetoquinol SA — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

72.6 / 75.1Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.